Zobrazeno 1 - 8
of 8
pro vyhledávání: '"521"'
Autor:
Ripollone JE; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Huybrechts KF; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Rothman KJ; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; Research Triangle Institute, Research Triangle Park, North Carolina, USA., Ferguson RE; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; VA Boston Healthcare System, Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts, USA., Franklin JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Sep; Vol. 29 (9), pp. 1194-1197. Date of Electronic Publication: 2020 Aug 10.
Autor:
Glynn RJ; Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Lunt M; The Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, UK., Rothman KJ; RTI Health Solutions, and the Department of Epidemiology, Boston University, Boston, Massachusetts., Poole C; Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina., Schneeweiss S; Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Stürmer T; Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2019 Oct; Vol. 28 (10), pp. 1290-1298. Date of Electronic Publication: 2019 Aug 05.
Autor:
Gayatri Ranganathan, Alvaro Morales, Philip W. Kantoff, Varant Kupelian, Liane J. Tinsley, Gary A. Wittert, Jennifer L. Lund, Susan A. Hall, Andre B. Araujo
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:498-506
Purpose Prescription testosterone (T) has limited approved medical indications and is a controlled substance in Canada. Utilization studies in other Westernized countries have revealed sharp increases in T use in recent years. We examined medical use
Autor:
James Nuovo, Curtis Sather
Publikováno v:
Pharmacoepidemiology and Drug Safety. 16:349-351
Purpose How randomized controlled trial results are reported may minimize concerns and detection of adverse side effects. We aimed to describe the methods of reporting adverse events in these published trials. Methods Five frequently cited journals w
Autor:
Hall SA; Department of Epidemiology, New England Research Institutes, Watertown, MA, USA., Ranganathan G, Tinsley LJ, Lund JL, Kupelian V, Wittert GA, Kantoff PW, Morales A, Araujo AB
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2014 May; Vol. 23 (5), pp. 498-506. Date of Electronic Publication: 2014 Feb 07.
Autor:
Grimmsmann T; Medical Review Board of the Statutory Health Insurance Funds Mecklenburg-Vorpommern, Schwerin, Germany., Himmel W
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2009 Dec; Vol. 18 (12), pp. 1206-13.
Autor:
Amann U; Institute for Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany. ute.amann@t-online.de, Egen-Lappe V, Strunz-Lehner C, Hasford J
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2006 May; Vol. 15 (5), pp. 327-37.